Wouter Van Overbeke

An ER-directed gelsolin nanobody targets the first step in amyloid formation in a gelsolin amyloidosis mouse model.

W. Derave, R. Robinson, J. Haigh, 2015, Human molecular genetics.

AAV9 delivered bispecific nanobody attenuates amyloid burden in the gelsolin amyloidosis mouse model

W. Derave, N. Devoogdt, J. Gettemans, 2017, Human molecular genetics.

Chaperone nanobodies protect gelsolin against MT1-MMP degradation and alleviate amyloid burden in the gelsolin amyloidosis mouse model.

J. Vandekerckhove, W. Derave, J. Gettemans, 2014, Molecular therapy : the journal of the American Society of Gene Therapy.

Non-Invasive Imaging of Amyloid Deposits in a Mouse Model of AGel Using 99mTc-Modified Nanobodies and SPECT/CT

N. Devoogdt, J. Gettemans, T. Lahoutte, 2016, Molecular Imaging and Biology.